GGrantIndex
Sort

40,608 grants matching prostate cancer

INBRE: WINTHROP U: FACULTY & UNDERGRADUATE RESEARCH DEVELOPMENT

$438,634
Patrick Owens · University Of South Carolina At Columbia · P20 · FY2010 · RR

Mechanisms of Testosterone Action

$438,555
Shalendar Bhasin · Boston Medical Center · R01 · FY2012 · AG

Redefining Normal: personalized CA125 cutpoints for ovarian cancer screening

$438,367
Kathryn L Terry · Brigham And Women'S Hospital · R01 · FY2016 · CA

PROSTATE, LUNG, COLORECTAL, &OVARIAN CANCER SCREENING

$438,347
Westat, Inc. · N01 · FY2000 · CN

Academic-Industrial Partnership for Translation of Acoustic Angiography

$438,329
Paul A Dayton · Univ Of North Carolina Chapel Hill · R01 · FY2015 · CA

Project 1- Role of fat in metastatic engraftment and expansion in the liver

$438,217
Neil A Bhowmick · Cedars-Sinai Medical Center · P01 · FY2024 · CA

Role of STEAP2 protein in hepatocarcinogenesis

$438,140
Luzhe Sun · University Of Texas Hlth Science Center · R01 · FY2021 · CA

TMPRSS2-ERG chromosomal translocations and prostate cancer

$438,013
Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Multilevel Mediation Analysis to Explore Racial Disparities in Breast Cancer Recurrence and Survival using CDC Special Studies

$438,000
Qingzhao Yu · Lsu Health Sciences Center · R15 · FY2017 · MD

Technology for Optimizing Population Care in a Resource-limited Environment

$437,935
Steven J Atlas · Massachusetts General Hospital · R18 · FY2009 · HS

Selenium Chemoprevention: Benefits and Harms

$437,924
Elizabeth T Jacobs · University Of Arizona · R01 · FY2019 · CA

Targeting early events in prostate cancer lineage plasticity

$437,922
Scott M. Dehm · University Of Minnesota · R01 · FY2024 · CA

Post-translational SOX2 modification - a regulatory switch between self-renewal and differentiation in squamous cell carcinoma

$437,810
Markus Schober · New York University School Of Medicine · R01 · FY2024 · CA

AFRICAN AMERICAN COMMUNITY REVIEW OF GENETIC RESEARCH

$437,805
University Of Oklahoma Norman · R01 · FY2001 · ES

Modulators of Prostate Cancer Metastasis

$437,774
Bruce R Zetter · Boston Children'S Hospital · R01 · FY2014 · CA

Defining Response and Resistance to PI3K and AR inhibition in Prostate Cancer

$437,769
Brett Stewart Carver · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA

Substrate Specificity Determinants in Nutrient Solute Carrier Transporters

$437,751
Avner Schlessinger · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA

SUPERHYDROPHOBIC DRUG LOADED BUTTRESSES FOR PREVENTION OF LUNG TUMOR RECURRENCE

$437,722
Mark W Grinstaff · Boston University (Charles River Campus) · R01 · FY2021 · CA

Ras-mediated signals in human epithelial cell transformation and metastasis

$437,665
Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Studies of Non-Ionizing Radiation-Related Cancer

$437,644
Peter D Inskip · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA

Studies of Proteins with Important Roles in Immunology andor Cancer Biology

$437,637
Jacek T Lubkowski · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

Admixture Mapping of Glaucoma Genes in African Americans

$437,609
Michael A Hauser · Duke University · R01 · FY2009 · EY

TARGETING ENDOGLIN SIGNALING TO ANTAGONIZE ANDROGEN RECEPTOR SPLICE VARIANTS IN CASTRATE RESISTANT PROSTATE CANCER

$437,500
Cedars-Sinai Medical Center · · FY2017 · Department of the Army

Association of inflammatory genes and prostate cancer

$437,498
Jianfeng Xu · Wake Forest University Health Sciences · R01 · FY2007 · CA

Evaluate long-term prognosis of localized prostate cancer following initial radia

$437,433
Grace Lu-Yao · Univ Of Med/Dent Nj-R W Johnson Med Sch · RC1 · FY2010 · CA